All Stories

  1. Detection of hemophagocytic extremely multinucleated giant plasma cells after rituximab/low-dose lenalidomide treatment in CD20+ multiple myeloma

    Article • Leukemia & Lymphoma, February 2019, Taylor & Francis

    Albrecht Reichle

  2. Biomodulatory metronomic therapy in stage IV melanoma is well‐tolerated and may induce prolonged progression‐free survival, a phase I trial

    Article • Journal of the European Academy of Dermatology and Venereology, September 2015, Wiley

    Albrecht Reichle

  3. Biomodulatory metronomic therapy induces PET-negative remission in chemo- and brentuximab-refractory Hodgkin lymphoma

    Article • British Journal of Haematology, May 2015, Wiley

    Professor Dr. Dirk Hellwig , Albrecht Reichle

  4. Combined Modularized Tumor Therapy—Tumor Biology—and Prognostic Factors: Bioengineering Tumor Response

    Article • January 2013, Springer Science + Business Media

    Albrecht Reichle

  5. Communication—Evolution—Pathophysiology: An Endogenous Conjunction—Instead of an Introduction

    Article • January 2013, Springer Science + Business Media

    Albrecht Reichle

  6. Bridging a Diagnostic and Therapeutic Gap: Selecting, Assessing and Categorizing, Tumor-associated Normative Notions

    Article • January 2013, Springer Science + Business Media

    Albrecht Reichle

  7. Including Rationalizations of Tumor-Associated Normative Notions in Pathophysiologic Considerations: Communication-Theoretical Implications

    Article • January 2013, Springer Science + Business Media

    Albrecht Reichle

  8. The Subjectivity of Systems Objects as a Scientific Object

    Article • January 2013, Springer Science + Business Media

    Albrecht Reichle

  9. Biomodulatory Therapy Approaches in Renal Clear Cell Carcinoma: A Perspective

    Article • January 2013, Springer Science + Business Media

    Albrecht Reichle

  10. Turning Upside Down the Mode of Science to Emphasize and Harness the Impact of Environmental Communication

    Article • January 2013, Springer Science + Business Media

    Albrecht Reichle

  11. Modularity, Subjectivity, Intersubjectivity and Normativity: Clinically Applicable Operative Benchmarks

    Article • January 2013, Springer Science + Business Media

    Albrecht Reichle

  12. Evolution-adjusted Tumor Pathophysiology:

    Article • January 2013, Springer Science + Business Media

    Albrecht Reichle

  13. Bridging Theory and Therapeutic Practice: From Generalized Disease Models to Particular Patients

    Article • January 2010, Springer Science + Business Media

    Albrecht Reichle

  14. Searching for the ‘Metabolism’ of Evolution

    Article • January 2010, Springer Science + Business Media

    Albrecht Reichle

  15. Principles of Modular Tumor Therapy

    Article • January 2010, Springer Science + Business Media

    Albrecht Reichle

  16. A Methodological Approach to Personalized Therapies in Metastatic Cancer

    Article • January 2010, Springer Science + Business Media

    Albrecht Reichle

  17. Uncovering Tumor Systems Biology by Biomodulatory Therapy Strategies

    Article • January 2010, Springer Science + Business Media

    Albrecht Reichle

  18. Systems Biology: A Therapeutic Target for Tumor Therapy

    Article • January 2010, Springer Science + Business Media

    Albrecht Reichle

  19. To Be an Object in a Biological System

    Article • January 2010, Springer Science + Business Media

    Albrecht Reichle

  20. From Molecular to Modular Tumor Therapy

    Article • January 2010, Springer Science + Business Media

    Albrecht Reichle

  21. Principles of Modular Tumor Therapy

    Article • Cancer Microenvironment, July 2009, Springer Science + Business Media

    Albrecht Reichle

  22. Systems Biology: A Therapeutic Target for Tumor Therapy

    Article • Cancer Microenvironment, July 2008, Springer Science + Business Media

    Albrecht Reichle

  23. Conventional Therapeutics with Antiangiogenic Activity

    Article • July 2007, Taylor & Francis

    Albrecht Reichle